Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Effect of increased CRM₁₉₇ carrier protein dose on meningococcal C bactericidal antibody response.

Lee LH, Blake MS.

Clin Vaccine Immunol. 2012 Apr;19(4):551-6. doi: 10.1128/CVI.05438-11. Epub 2012 Feb 15.

2.

Suppressive effect of bacterial polysaccharides on BAFF system is responsible for their poor immunogenicity.

Kanswal S, Katsenelson N, Allman W, Uslu K, Blake MS, Akkoyunlu M.

J Immunol. 2011 Feb 15;186(4):2430-43. doi: 10.4049/jimmunol.1002976. Epub 2011 Jan 19.

3.

Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.

Osorio M, Wu Y, Singh S, Merkel TJ, Bhattacharyya S, Blake MS, Kopecko DJ.

Infect Immun. 2009 Apr;77(4):1475-82. doi: 10.1128/IAI.00828-08. Epub 2009 Jan 29.

4.

Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14.

Kocabas C, Katsenelson N, Kanswal S, Kennedy MN, Cui X, Blake MS, Segal DM, Akkoyunlu M.

Cell Microbiol. 2007 May;9(5):1297-310. Epub 2007 Jan 22.

PMID:
17250593
5.

Doubly branched hexasaccharide epitope on the cell wall polysaccharide of group A streptococci recognized by human and rabbit antisera.

Michon F, Moore SL, Kim J, Blake MS, Auzanneau FI, Johnston BD, Johnson MA, Pinto BM.

Infect Immun. 2005 Oct;73(10):6383-9.

6.

Meningococcal vaccine development: a novel approach.

Fusco PC, Blake MS, Michon F.

Expert Opin Investig Drugs. 1998 Feb;7(2):245-52.

PMID:
15991955
7.

Neisseria gonorrhoeae porin, P.IB, causes release of ATP from yeast actin.

Wen KK, Blake MS, Rubenstein PA.

J Muscle Res Cell Motil. 2004;25(4-5):343-50.

PMID:
15548863
8.

Identification of peptides that mimic the pertussis toxin binding site on bovine fetuin.

Bogdan JA, Yuan W, Long-Rowe KO, Sarwar J, Brucker EA, Blake MS.

Appl Environ Microbiol. 2003 Oct;69(10):6272-9.

9.

A co-operative interaction between Neisseria gonorrhoeae and complement receptor 3 mediates infection of primary cervical epithelial cells.

Edwards JL, Brown EJ, Uk-Nham S, Cannon JG, Blake MS, Apicella MA.

Cell Microbiol. 2002 Sep;4(9):571-84.

PMID:
12390350
10.

A one-step method for genetic transformation of non-piliated Neisseria meningitidis.

Bogdan JA, Minetti CA, Blake MS.

J Microbiol Methods. 2002 Mar;49(1):97-101.

PMID:
11777587
11.

Bordetella pertussis autoregulates pertussis toxin production through the metabolism of cysteine.

Bogdan JA, Nazario-Larrieu J, Sarwar J, Alexander P, Blake MS.

Infect Immun. 2001 Nov;69(11):6823-30.

12.

Interaction of the gonococcal porin P.IB with G- and F-actin.

Wen KK, Giardina PC, Blake MS, Edwards J, Apicella MA, Rubenstein PA.

Biochemistry. 2000 Jul 25;39(29):8638-47.

PMID:
10913272
13.

Gonococcal lipooligosaccharide is a ligand for the asialoglycoprotein receptor on human sperm.

Harvey HA, Porat N, Campbell CA, Jennings M, Gibson BW, Phillips NJ, Apicella MA, Blake MS.

Mol Microbiol. 2000 Jun;36(5):1059-70.

14.

The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin.

Mackinnon FG, Ho Y, Blake MS, Michon F, Chandraker A, Sayegh MH, Wetzler LM.

J Infect Dis. 1999 Sep;180(3):755-61.

PMID:
10438364
15.

Meningococcal PorA/C1, a channel that combines high conductance and high selectivity.

Song J, Minetti CA, Blake MS, Colombini M.

Biophys J. 1999 Feb;76(2):804-13.

16.

Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine.

Fusco PC, Michon F, Laude-Sharp M, Minetti CA, Huang CH, Heron I, Blake MS.

Vaccine. 1998 Nov;16(19):1842-9.

PMID:
9795390
17.

Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein.

Michon F, Fusco PC, Minetti CA, Laude-Sharp M, Uitz C, Huang CH, D'Ambra AJ, Moore S, Remeta DP, Heron I, Blake MS.

Vaccine. 1998 Nov;16(18):1732-41.

PMID:
9778749
20.

Biophysical and antigenic characterization of gonococcal protein I incorporated into liposomes.

Parmar MM, Blake MS, Madden TD.

Vaccine. 1997 Oct;15(15):1641-51.

PMID:
9364695
21.
22.
23.

Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodies.

Zabriskie JB, Poon-King T, Blake MS, Michon F, Yoshinaga M.

Adv Exp Med Biol. 1997;418:917-9.

PMID:
9331798
24.

Combination conjugate vaccines against multiple serotypes of group B streptococci.

Michon F, Fusco PC, D'Ambra AJ, Laude-Sharp M, Long-Rowe K, Blake MS, Tai JY.

Adv Exp Med Biol. 1997;418:847-50. No abstract available.

PMID:
9331785
25.

Bactericidal activity elicited by the beta C protein of group B streptococci contrasted with capsular polysaccharides.

Fusco PC, Perry JW, Liang SM, Blake MS, Michon F, Tai JY.

Adv Exp Med Biol. 1997;418:841-5. No abstract available.

PMID:
9331784
26.

Structure-function studies with Neisseria gonorrhoeae Opa outer membrane proteins expressed in Escherichia coli.

Simon D, Liu JT, Blake MS, Blake CR, Rest RF.

Ann N Y Acad Sci. 1996 Oct 25;797:253-4. No abstract available.

PMID:
8993370
27.
28.

Protein B: an important human IgA-binding reagent.

Grundy MA, Blake MS, Murray K.

Ann N Y Acad Sci. 1996 Feb 13;778:384-7.

PMID:
8610998
29.

Vaccines for gonorrhea: where are we on the curve?

Blake MS, Wetzler LM.

Trends Microbiol. 1995 Dec;3(12):469-74. Review.

PMID:
8800838
30.
32.

Gonococcal opacity: lectin-like interactions between Opa proteins and lipooligosaccharide.

Blake MS, Blake CM, Apicella MA, Mandrell RE.

Infect Immun. 1995 Apr;63(4):1434-9.

33.

Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies.

Salvadori LG, Blake MS, McCarty M, Tai JY, Zabriskie JB.

J Infect Dis. 1995 Mar;171(3):593-600.

PMID:
7876606
34.

Production of Haemophilus influenzae type-b porin in Escherichia coli and its folding into the trimeric form.

Pullen JK, Liang SM, Blake MS, Mates S, Tai JY.

Gene. 1995 Jan 11;152(1):85-8.

PMID:
7828934
35.

Serum resistance of Neisseria gonorrhoeae. Does it thwart the inflammatory response and facilitate the transmission of infection?

Rice PA, McQuillen DP, Gulati S, Jani DB, Wetzler LM, Blake MS, Gotschlich EC.

Ann N Y Acad Sci. 1994 Aug 15;730:7-14.

PMID:
8080215
37.

Processing of bone marrow for transplantation: development of a mononuclear cell enrichment protocol.

Hollingsworth KL, Williams SF, Blake MS, Pothiawala M, Mick R, Larson RA, Bender JG.

Prog Clin Biol Res. 1994;389:695-704. No abstract available.

PMID:
7700937
38.

GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3.

Livingston PO, Calves MJ, Helling F, Zollinger WD, Blake MS, Lowell GH.

Vaccine. 1993 Sep;11(12):1199-204.

PMID:
8256501
39.

Shift in S-layer protein expression responsible for antigenic variation in Campylobacter fetus.

Wang E, Garcia MM, Blake MS, Pei Z, Blaser MJ.

J Bacteriol. 1993 Aug;175(16):4979-84.

40.
41.

The major outer membrane protein of Haemophilus ducreyi is a member of the OmpA family of proteins.

Spinola SM, Griffiths GE, Shanks KL, Blake MS.

Infect Immun. 1993 Apr;61(4):1346-51.

42.

Antibodies against IgA1 protease are stimulated both by clinical disease and asymptomatic carriage of serogroup A Neisseria meningitidis.

Brooks GF, Lammel CJ, Blake MS, Kusecek B, Achtman M.

J Infect Dis. 1992 Dec;166(6):1316-21.

PMID:
1431249
43.

Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants.

Wetzler LM, Blake MS, Barry K, Gotschlich EC.

J Infect Dis. 1992 Sep;166(3):551-5.

PMID:
1323620
44.

Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera.

Wetzler LM, Barry K, Blake MS, Gotschlich EC.

Infect Immun. 1992 Jan;60(1):39-43.

46.

Colony morphology of piliated Neisseria meningitidis.

Blake MS, MacDonald CM, Klugman KP.

J Exp Med. 1989 Nov 1;170(5):1727-36.

48.

The construction and characterization of Neisseria gonorrhoeae lacking protein III in its outer membrane.

Wetzler LM, Gotschlich EC, Blake MS, Koomey JM.

J Exp Med. 1989 Jun 1;169(6):2199-209.

49.

Protein III: structure, function, and genetics.

Blake MS, Wetzler LM, Gotschlich EC, Rice PA.

Clin Microbiol Rev. 1989 Apr;2 Suppl:S60-3. Review. No abstract available.

50.

Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies.

Wetzler LM, Blake MS, Gotschlich EC.

Trans Assoc Am Physicians. 1989;102:78-90. No abstract available.

PMID:
2561644

Supplemental Content

Loading ...
Support Center